• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性卵巢癌的影像学策略:实用综述。

Imaging strategy in recurrent ovarian cancer: a practical review.

机构信息

Department of Radiological, Oncological and Pathological Science, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

Department of Gynaecological, Obstetrical and Urological Science, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

出版信息

Abdom Radiol (NY). 2019 Mar;44(3):1091-1102. doi: 10.1007/s00261-018-1677-y.

DOI:10.1007/s00261-018-1677-y
PMID:29987401
Abstract

Ovarian cancer is one of the most aggressive gynaecologic malignancies in women worldwide. The lack of proper screening programs and the characteristic abdominal spreading with minimal clinical symptoms give rise of its high lethality. Most patients show advanced disease at diagnosis and have a poor prognosis. The surveillance of ovarian cancer patients after initial treatment is a challenging question in clinical practice and there is no consensus in literature about the most appropriate follow-up strategy for these women. The role of Imaging has become increasingly important, allowing to properly monitor patients, distinguishing the different relapse patterns, thus guiding the correct management and therapy. In this review, we report and analyze the scientific evidence about the role of the different imaging modalities now available in the follow-up strategy and management of Epithelial Ovarian Cancer patients with recurrent disease.

摘要

卵巢癌是全球女性中最具侵袭性的妇科恶性肿瘤之一。由于缺乏适当的筛查计划以及其特征性的腹部扩散和最小的临床症状,导致其致死率很高。大多数患者在诊断时已处于晚期疾病状态,预后较差。在初始治疗后对卵巢癌患者进行监测是临床实践中的一个难题,目前文献中对于这些女性最适当的随访策略尚无共识。影像学的作用变得越来越重要,它可以正确监测患者,区分不同的复发模式,从而指导正确的管理和治疗。在这篇综述中,我们报告和分析了关于不同影像学手段在复发性上皮性卵巢癌患者的随访策略和管理中的作用的科学证据。

相似文献

1
Imaging strategy in recurrent ovarian cancer: a practical review.复发性卵巢癌的影像学策略:实用综述。
Abdom Radiol (NY). 2019 Mar;44(3):1091-1102. doi: 10.1007/s00261-018-1677-y.
2
Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.¹⁸F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在复发性上皮性卵巢癌中的诊断价值:134 例患者二次细胞减灭术患者选择的准确性。
J Gynecol Oncol. 2018 May;29(3):e36. doi: 10.3802/jgo.2018.29.e36. Epub 2018 Feb 1.
3
Low-grade epithelial ovarian cancer: what a radiologist should know.低度恶性上皮性卵巢癌:放射科医生应了解的内容。
Br J Radiol. 2019 Mar;92(1095):20180571. doi: 10.1259/bjr.20180571. Epub 2019 Jan 31.
4
Clinical Value of F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在晚期上皮性卵巢癌初始治疗后疗效评估中的临床价值。
Clin Oncol (R Coll Radiol). 2018 Aug;30(8):507-514. doi: 10.1016/j.clon.2018.04.007. Epub 2018 May 9.
5
The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.F18-FDG PET/CT在预测复发性卵巢癌患者二次最佳肿瘤细胞减灭术中的作用。
Surg Oncol. 2017 Dec;26(4):347-351. doi: 10.1016/j.suronc.2017.07.004. Epub 2017 Jul 13.
6
Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose ([F] FDG) in the detection of recurrent ovarian cancer.CA125 及其动力学参数和正电子发射断层扫描/计算机断层扫描(PET/CT)联合氟脱氧葡萄糖 ([F] FDG) 在复发性卵巢癌检测中的应用。
Med Clin (Barc). 2018 Aug 10;151(3):97-102. doi: 10.1016/j.medcli.2017.11.019. Epub 2017 Dec 21.
7
[Diagnostic value of imaging (ultrasonography, doppler, CT, MR, PET-CT) for the diagnosis of a suspicious ovarian mass and staging of ovarian, tubal or primary peritoneal cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].[影像学检查(超声、多普勒、CT、MR、PET-CT)对可疑卵巢肿块诊断及卵巢、输卵管或原发性腹膜癌分期的诊断价值:本文依据法国肿瘤学指南“上皮性卵巢癌患者的初始治疗”起草,该指南由FRANCOGYN、CNGOF、SFOG、GINECO-ARCAGY在CNGOF的支持下制定,并得到了法国国家癌症研究所(INCa)的认可]
Gynecol Obstet Fertil Senol. 2019 Feb;47(2):123-133. doi: 10.1016/j.gofs.2018.12.012. Epub 2019 Jan 25.
8
ACR Appropriateness Criteria Staging and Follow-Up of Ovarian Cancer.ACR 适宜性标准:卵巢癌的分期和随访。
J Am Coll Radiol. 2018 May;15(5S):S198-S207. doi: 10.1016/j.jacr.2018.03.015.
9
Isolated Urethral Metastasis From a Primary Ovarian Malignancy.原发性卵巢恶性肿瘤的孤立性尿道转移
J Obstet Gynaecol Can. 2018 Dec;40(12):1632-1634. doi: 10.1016/j.jogc.2018.05.012. Epub 2018 Sep 24.
10
Magnetic resonance imaging in categorization of ovarian epithelial cancer and survival analysis with focus on apparent diffusion coefficient value: correlation with Ki-67 expression and serum cancer antigen-125 level.磁共振成像在卵巢上皮性癌的分类及生存分析中的应用,重点关注表观扩散系数值:与 Ki-67 表达和血清癌抗原 125 水平的相关性。
J Ovarian Res. 2019 Jun 26;12(1):59. doi: 10.1186/s13048-019-0534-0.

引用本文的文献

1
CT-based radiomics predicts HRD score and HRD status in patients with ovarian cancer.基于CT的影像组学可预测卵巢癌患者的HRD评分和HRD状态。
Front Oncol. 2025 Jan 8;14:1477759. doi: 10.3389/fonc.2024.1477759. eCollection 2024.
2
Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine.肽类正电子发射断层显像(PET)成像:近期进展综述及放射性金属标记肽类在医学领域的未来展望
Chem Biomed Imaging. 2024 Aug 23;2(9):615-630. doi: 10.1021/cbmi.4c00030. eCollection 2024 Sep 23.
3
Gynecologic Cancer InterGroup CA125 response has a high negative predictive value for CHK1 inhibitor RECIST response in recurrent ovarian cancer.
妇科癌症 INTERGROUP CA125 反应对复发性卵巢癌 CHK1 抑制剂 RECIST 反应具有高阴性预测价值。
Sci Rep. 2024 Jul 29;14(1):17459. doi: 10.1038/s41598-024-68338-2.
4
Gynecologic oncology tumor board: the central role of the radiologist.妇科肿瘤肿瘤委员会:放射科医生的核心作用。
Abdom Radiol (NY). 2023 Oct;48(10):3265-3279. doi: 10.1007/s00261-023-03978-y. Epub 2023 Jun 29.
5
Tumor-Bowel Fistula as a Rare Form of Recurrent Ovarian Cancer-Imaging and Treatment: Preliminary Report.肿瘤-肠瘘作为一种罕见的复发性卵巢癌的形式——影像学和治疗:初步报告。
Curr Oncol. 2022 Dec 29;30(1):506-517. doi: 10.3390/curroncol30010040.
6
Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review.铂敏感复发性卵巢癌二次肿瘤细胞减灭术的最新进展:一项叙述性综述
Ann Transl Med. 2021 Mar;9(6):510. doi: 10.21037/atm-20-4690.
7
Improved prognosis for recurrent epithelial ovarian cancer by early diagnosis and 125I seeds implantation during suboptimal secondary cytoreductive surgery: a case report and literature review.早期诊断和在次优二次细胞减灭术中植入 125I 种子可改善复发性上皮性卵巢癌的预后:病例报告和文献复习。
J Ovarian Res. 2020 Nov 30;13(1):141. doi: 10.1186/s13048-020-00744-2.